acut
chronic
inflammatori
respons
lung
associ
accumul
larg
quantiti
immun
structur
cell
undergo
apoptosi
need
engulf
phagocyt
process
call
efferocytosi
apoptot
cell
recognit
remov
lung
mediat
predominantli
airway
macrophag
though
immatur
dendrit
cell
nonprofession
phagocyt
epitheli
cell
mesenchym
cell
also
display
function
effici
clearanc
apoptot
cell
airway
essenti
success
resolut
inflamm
return
lung
homeostasi
disrupt
process
lead
secondari
necrosi
accumul
apoptot
cell
releas
necrot
cell
debri
subsequ
uncontrol
inflammatori
activ
innat
immun
system
releas
damag
associ
molecular
pattern
damp
control
durat
immun
respons
prevent
autoimmun
reaction
antiinflammatori
signal
cascad
initi
phagocyt
upon
apoptot
cell
uptak
mediat
rang
receptor
recognis
specif
phospholipid
protein
externalis
secret
apoptot
cell
howev
prolong
activ
apoptot
cell
recognit
receptor
famili
receptor
tyrosin
kinas
axl
mertk
tam
may
delay
prevent
inflammatori
respons
subsequ
infect
review
discuss
recent
advanc
submiss
relat
immunopatholog
lung
diseas
dr
understand
mechan
control
apoptot
cell
recognit
remov
lung
homeostasi
inflamm
contribut
defect
efferocytosi
chronic
inflammatori
lung
diseas
chronic
obstruct
pulmonari
diseas
asthma
cystic
fibrosi
implic
signal
trigger
apoptot
cell
suscept
pulmonari
microbi
infect
keyword
efferocytosi
phosphatidylserin
apoptot
cell
clearanc
lung
airway
macrophag
inflamm
cellular
turnov
occur
part
normal
homeostat
process
vital
contract
cell
recruit
inflammatori
respons
biolog
process
becom
appar
turnov
cell
regul
tissuespecif
manner
specif
primarili
driven
local
produc
factor
exampl
uniqu
microenviron
airspac
drive
distinct
express
pattern
apoptot
cell
recognit
receptor
airway
macrophag
compar
tissueresid
macrophag
anatom
locat
airway
cell
turnov
primarili
mediat
induct
apoptosi
follow
engulf
apoptot
cell
phagocyt
call
efferocytosi
term
efferocytosi
coin
separ
engulf
apoptot
cell
form
phagocytosi
deriv
latin
word
effer
translat
take
grave
phagocytosi
pathogen
requir
initi
inflammatori
respons
remov
selfcel
undergo
apoptosi
tolerogen
process
prevent
excess
inflamm
andor
autoimmun
caus
releas
damag
associ
molecular
pattern
damp
apoptot
cell
clear
time
manner
undergo
secondari
necrosi
achiev
distinct
macrophag
phagocyt
utilis
differ
set
receptor
recognis
microbi
particl
cell
undergo
apoptosi
activ
subsequ
lead
distinct
cell
activ
programm
wherea
phagocytosi
pathogen
trigger
conserv
proinflammatori
signal
pathway
engulf
apoptot
cell
phagocyt
may
promot
wound
repair
process
product
factor
curtail
inflamm
secret
growth
factor
shape
develop
tissu
efferocytosi
therefor
lead
differ
consequ
burgeon
focu
research
driven
discoveri
ever
apoptot
cell
recognit
receptor
importantli
pathogen
use
apoptot
cell
clearanc
process
facilit
entri
host
cell
andor
subvert
antipathogen
immun
distinct
apoptot
healthi
cell
mediat
primarili
releas
findm
signal
apoptot
cell
includ
atp
utp
fractalkin
lysophosphatidylcholin
addit
recruit
solubl
signal
may
also
enhanc
engulf
capac
respond
cell
exampl
apoptot
cell
product
fractalkin
induc
milk
fat
globuleepiderm
growth
factor
express
phagocyt
enhanc
apoptot
cell
clearanc
apoptot
cell
expos
varieti
molecul
cell
surfac
recognis
receptor
phagocyt
cell
precis
composit
eatm
signal
like
depend
whether
apoptosi
occur
homeostat
condit
inflamm
tissueand
cell
typespecif
one
best
studi
eatm
signal
phosphatidylserin
ptdser
live
cell
localis
inner
leaflet
plasma
membran
externalis
upon
induct
apoptosi
overexpress
ptdser
enhanc
apoptot
cell
engulf
wherea
ptdser
blockad
suppress
process
lead
autoimmun
irrevers
externalis
occur
caspas
inactiv
flippas
healthi
cell
continu
flip
ptdser
plasma
membran
time
caspasedepend
activ
scramblas
nonspecif
bidirect
scrambl
phospholipid
plasma
membran
also
requir
ptdser
exposur
apoptot
cell
ptdser
transient
expos
surfac
live
cell
resist
efferocytosi
suggest
signal
alon
may
enough
prolong
interact
ptdser
receptor
phagocyt
requir
oxidis
lowdens
lipoprotein
calreticulin
annexin
also
implic
efferocytosi
furthermor
healthi
cell
prevent
engulf
express
ligat
imped
macrophag
function
balanc
efferocytosisinduc
inhibitori
signal
may
therefor
determin
apoptot
cell
clearanc
ptdser
eatm
signal
expos
apoptot
cell
bind
plethora
receptor
phagocyt
cell
number
identifi
lung
tabl
externalis
ptdser
recognis
directli
trigger
receptor
express
myeloid
receptor
advanc
glycat
end
product
rage
brainspecif
angiogenesi
famili
celltransmembran
immunoglobulin
mucin
tim
receptor
includ
engulf
receptor
requir
bridg
molecul
link
externalis
ptdser
exampl
integrin
requir
axl
mertk
form
tam
receptor
tyrosin
kinas
famili
requir
bridg
molecul
protein
growth
arrest
specif
ntermin
gla
domain
protein
bridg
tam
receptor
ptdser
surfac
apoptot
cell
wherea
ctermin
sex
hormonebind
globulinlik
domain
bind
activ
tam
receptor
also
number
receptor
recognis
externalis
ligand
includ
scaveng
receptor
class
f
member
ldl
receptorrel
also
known
recognis
calreticulin
respect
togeth
integrin
recognis
bind
modifi
form
intracellular
adhes
molecul
lectin
receptor
recognis
alter
sugar
logic
behind
possess
mani
receptor
recognis
apoptot
cell
entir
clear
act
tether
receptor
without
signal
consequ
similar
differ
receptor
may
also
act
differ
stage
efferocytosi
may
preferenti
clear
cell
differ
locat
exampl
form
receptorligand
pair
connect
microglia
apoptot
neuron
direct
remov
damag
cell
allow
repair
also
like
altern
outcom
requir
upon
efferocytosi
requir
linkag
differ
signal
compon
regard
tam
receptor
mertk
ubiquit
express
macrophag
even
use
defin
marker
airway
macrophag
howev
unlik
macrophag
constitut
express
axl
possibl
due
local
environ
rich
granulocytemacrophag
colonystimul
factor
gmcsf
importantli
receptor
recognis
apoptot
cell
also
play
dual
function
induc
cytoskelet
rearrang
necessari
ingest
apoptot
cell
also
transmit
instruct
signal
interest
note
individu
tam
receptor
famili
member
use
differ
molecul
bridg
ptdser
externalis
apoptot
cell
mertk
activ
protein
wherea
sole
ligand
axl
case
mertk
therefor
possibl
specif
signal
trigger
receptor
ligat
might
differ
depend
bridg
molecul
though
possibl
remain
verifi
experiment
final
select
respons
afford
cooper
multipl
receptor
axl
dendrit
cell
axl
tether
apoptot
cell
dendrit
cell
requir
trigger
internalis
receptor
mediat
efferocytosi
often
antiinflammatori
signal
consequ
chang
phenotyp
function
ingest
cell
exampl
engag
activ
tam
receptor
inhibit
signal
pathway
trigger
cytokin
tolllik
receptor
ligand
induct
suppressor
cytokin
see
fig
b
impact
apoptot
cell
clearanc
cell
function
depend
cell
type
mediat
efferocytosi
turn
depend
tissu
locat
lung
efferocytosi
mediat
predominantli
macrophag
airway
epitheli
cell
consequ
studi
former
macrophag
efferocytosi
increas
secret
antiinflammatori
cytokin
transform
growth
interleukin
il
inhibit
secret
proinflammatori
mediat
leukotrien
product
macrophag
upon
apoptot
cell
contact
part
depend
upon
scaveng
receptor
link
macrophag
apoptot
cell
cooper
integrin
efferocytosi
also
upregul
prostaglandin
impair
fcrmediat
phagocytosi
intratrach
instil
apoptot
cell
enhanc
resolut
lpsinduc
acut
pulmonari
inflamm
chang
function
proinflammatori
proresolut
observ
phenotyp
switch
macrophag
phenotyp
includ
induct
peroxisom
proliferatoractiv
howev
like
context
celltypeand
tissuedepend
exampl
nitric
oxid
mediat
immunosuppress
effect
induc
apoptot
cell
efferocytosi
dendrit
cell
also
interest
note
efferocytosi
dendrit
cell
appear
subsetspecif
murin
lung
dendrit
cell
captur
present
apoptot
cellassoci
antigen
health
diseas
wherea
hi
dendrit
cell
ingest
traffic
latex
bead
solubl
antigen
whether
due
select
express
receptor
recognis
apoptot
cell
phenotyp
switch
ingest
current
known
therefor
clearanc
apoptot
cell
profound
influenc
ingest
cell
though
outcom
predominantli
studi
macrophag
cell
type
particularli
dendrit
cell
also
like
affect
human
studi
integrin
low
express
human
confirm
mice
human
complex
integrin
confirm
human
low
express
mice
human
alter
sugar
lectin
receptor
mannos
receptor
confirm
mice
human
calreticulin
confirm
mice
human
studi
brainspecif
angiogenesi
intracellular
adhes
ldl
receptorrel
milk
fat
globuleepiderm
growth
factor
ptdser
phosphatidylserin
rage
receptor
advanc
glycat
end
product
scaveng
receptor
class
f
member
tim
celltransmembran
immunoglobulin
mucin
trigger
receptor
express
myeloid
tissu
cell
turnov
natur
homeostat
process
occur
predominantli
apoptosi
loss
plasma
membran
integr
time
remov
apoptot
cell
critic
prevent
autoimmun
reaction
cellular
constitu
howev
speed
turnov
determin
requir
local
phagocyt
system
term
capac
clear
accumul
apoptot
cell
often
govern
local
microenviron
past
inflamm
histori
healthi
murin
human
lung
airway
macrophag
make
cell
retriev
bronchoalveolar
lavag
exist
toler
state
due
interact
protein
receptor
express
secret
respiratori
epithelium
furthermor
mucu
bath
epithelium
contain
surfact
protein
dampen
macrophag
respons
health
chimer
mous
experi
show
resid
airway
macrophag
unusu
prolong
life
span
neglig
turnov
even
month
absenc
inflamm
situat
chang
follow
deplet
inflamm
replenish
peripheri
occur
lead
popul
macrophag
report
shorter
life
span
airway
macrophag
remov
irradi
lead
replenish
peripheri
higher
turnov
rate
approxim
day
howev
fate
resid
airway
macrophag
follow
pulmonari
infect
entir
clear
one
studi
show
macrophag
recruit
fig
mani
role
apoptot
cell
recognit
phagocytosi
immun
infect
efferocytosi
lead
remov
apoptot
cell
without
releas
content
apoptot
cell
engulf
time
manner
undergo
secondari
necrosi
releas
necrot
cell
debri
subsequ
caus
uncontrol
inflammatori
activ
innat
immun
system
releas
damag
associ
molecular
pattern
damp
b
apoptosi
cell
expos
phosphatidylserin
ptdser
outer
leaflet
membran
recognis
specif
receptor
express
phagocyt
recognit
ptdser
tam
receptor
bridg
molecul
protein
trigger
signal
cascad
converg
upregul
suppressor
cytokin
act
neg
regul
immun
respons
activ
tam
receptor
apoptot
cell
inhibit
product
proinflammatori
cytokin
promot
express
factor
suppress
inflamm
promot
tissu
repair
includ
c
envelop
virus
express
ptdser
envelop
use
ptdser
recognit
receptor
tam
tim
receptor
famili
promot
infect
host
cell
evad
immun
respons
microbi
infect
intracellular
pathogen
induct
apoptosi
infect
cell
one
strategi
host
immun
system
facilit
pathogen
clearanc
exampl
case
mycobacterium
tuberculosi
mtb
infect
necrosi
infect
cell
lead
dissemin
bacteria
wherea
engulf
infect
cell
undergo
apoptosi
allow
pathogen
destruct
airway
peripheri
influenza
infect
contract
fasdepend
apoptosi
number
resid
airway
macrophag
remain
unchang
wherea
anoth
impli
signific
ablat
resid
airway
macrophag
follow
replenish
interstiti
pool
discrep
might
aris
use
intranas
dye
becom
dilut
cell
divis
deplet
irradi
lung
protect
lead
order
track
definit
fate
airway
macrophag
follow
influenza
infect
report
mice
would
use
bone
marrow
emigr
becom
yfp
express
mice
requir
prior
manipul
distinguish
resid
versu
recruit
airway
cell
like
airway
macrophag
epitheli
cell
similarli
long
halflif
health
use
report
mice
ciliat
cell
progeni
track
across
lifetim
halflif
month
trachea
month
bronchiol
termin
bronchiol
estim
taken
togeth
observ
indic
homeostasi
rel
small
quantiti
apoptot
cell
appear
airway
due
slow
turnov
main
cell
popul
resid
healthi
lung
therefor
surpris
lung
phagocyt
effici
clear
scarc
apoptot
cell
even
efferocyt
function
partli
disrupt
exampl
delet
axl
highli
express
murin
airway
macrophag
caus
accumul
necrot
cell
debri
lung
inflamm
absenc
accompani
infect
despit
signific
impair
efferocyt
function
airway
macrophag
similarli
blockad
apoptot
cell
uptak
airway
epitheli
cell
cell
typespecif
delet
small
gtpase
requir
efferocytosi
mediat
sever
class
engulf
receptor
affect
integr
respons
epitheli
barrier
without
administr
exogen
apoptot
cell
induct
allerg
airway
inflamm
health
apoptot
cell
essenti
undetect
lung
tissu
immun
cell
infiltr
airway
undergo
apoptosi
rapidli
clear
airway
macrophag
model
acut
microbi
infectionrel
lung
inflamm
respiratori
infect
therefor
associ
persist
accumul
larg
quantiti
apoptot
cell
airspac
howev
increas
number
die
cell
detect
airspac
patient
sever
aetiolog
distinct
chronic
inflammatori
lung
diseas
although
higher
frequenc
apoptot
cell
diseas
might
result
either
elev
rate
apoptot
cell
death
defect
apoptot
cell
remov
experiment
evid
suggest
reduc
effici
efferocytosi
predominantli
airway
macrophag
play
key
role
patholog
process
comprehens
analysi
defect
apoptot
cell
clearanc
perform
chronic
obstruct
pulmonari
diseas
copd
chronic
lung
diseas
characteris
unresolv
inflamm
due
accumul
activ
neutrophil
cell
caus
smallairway
obstruct
peribronchi
fibrosi
andor
destruct
airway
wall
emphysema
patholog
process
lead
progress
destruct
lung
parenchyma
consequ
airflow
limit
fulli
revers
patient
emphysema
subtyp
copd
histor
lung
patholog
copd
attribut
alter
proteaseantiproteas
balanc
oxid
stress
caus
cigarett
smoke
main
risk
factor
copd
howev
evid
indic
import
role
aberr
apoptosi
apoptot
cell
clearanc
lung
damag
observ
copd
sever
report
demonstr
accumul
apoptot
epitheli
endotheli
immun
cell
lung
patient
copd
andor
emphysema
induct
structur
airway
cell
apoptosi
suffici
caus
emphysemat
chang
mice
seri
eleg
studi
hodg
cowork
demonstr
increas
number
apoptot
cell
detect
lung
patient
copd
attribut
significantli
impair
efferocyt
function
airway
macrophag
uptak
apoptot
bronchial
epitheli
cell
neutrophil
significantli
reduc
bronchoalveolar
lavag
macrophag
patient
copd
compar
healthi
control
defect
pronounc
copd
patient
current
smoke
observ
reduct
efferocyt
potenti
airway
macrophag
vitro
correl
frequenc
apoptot
bronchial
epitheli
cell
isol
bronchial
brush
associ
alter
express
sever
protein
involv
apoptot
cell
recognit
bind
includ
intriguingli
restor
copd
airway
macrophag
efferocyt
function
macrolid
antibiot
azithromycin
correl
chang
express
molecul
instead
depend
ptdser
bind
airway
macrophag
suggest
deregul
ptdserrecognis
receptor
bridg
molecul
might
respons
defect
apoptot
cell
remov
copd
neither
tam
tim
famili
ptdser
recognit
receptor
studi
copd
far
surprisingli
increas
express
mertk
observ
airway
macrophag
cigarett
smoker
also
characteris
impair
apoptot
cell
uptak
compar
cell
healthi
nonsmok
observ
indic
upregul
mertk
suffici
restor
efforocyt
function
airway
macrophag
normal
level
ptdser
receptor
axl
highli
express
mous
airway
macrophag
might
play
promin
role
apart
potenti
alter
ptdser
receptor
express
function
requir
detail
studi
sever
mechan
might
involv
efferocytosi
defect
observ
copd
signific
impair
apoptot
cell
uptak
airway
macrophag
smoker
indic
import
role
oxid
stress
caus
cigarett
smoke
compon
process
mice
cigarett
smoke
exposur
suffici
induc
emphysema
significantli
suppress
efferocytosi
airway
macrophag
vivo
vitro
effect
revers
treatment
antioxid
overexpress
extracellular
superoxid
dismutas
macrophag
phagocytosi
apoptot
cell
also
inhibit
alarmin
high
mobil
group
elev
level
airway
peripher
blood
patient
copd
recent
report
neg
correl
patient
lung
function
sinc
necrot
cell
main
sourc
extracellular
posit
feedback
loop
might
exist
copd
apoptot
cell
undergo
secondari
necrosi
releas
impair
efferocyt
function
airway
macrophag
turn
would
lead
accumul
greater
amount
necrot
debri
perpetu
chronic
inflamm
final
engulf
apoptot
cell
macrophag
also
regul
member
collectin
famili
ctype
lectin
level
mannosebind
lectin
mbl
promot
apoptot
cell
uptak
vitro
reduc
airway
patient
copd
correl
impair
macrophag
efferocytosi
surfact
protein
spa
spd
hand
play
complex
role
apoptot
cell
recognit
lung
homeostat
interact
spa
spd
signal
inhibitori
regulatori
express
airway
macrophag
suppress
efferocytosi
opsonis
apoptot
cell
spa
spd
interact
complex
enhanc
apoptot
cell
uptak
latter
seem
play
promin
role
chronic
lung
inflamm
spd
level
significantli
reduc
patient
copd
potenti
contribut
efferocytosi
defect
altern
downregul
spd
might
repres
physiolog
respons
lung
aim
overcom
suppress
macrophag
efferocyt
function
presenc
larg
amount
dead
cell
fail
effici
remov
apoptot
cell
copd
airway
due
phagocytosi
defect
asthma
obstruct
airway
diseas
characteris
hyperrespons
chronic
inflamm
respiratori
tract
neutrophil
predomin
cell
type
lung
copd
patient
asthma
repres
eosinophildomin
airway
inflamm
initi
prime
adapt
immun
system
airway
allergen
lead
activ
tissueresid
mast
cell
releas
broad
array
inflammatori
mediat
promot
migrat
eosinophil
airway
product
eosinophil
degranul
includ
major
basic
protein
eosinophil
cation
protein
reactiv
oxygen
speci
cytotox
epitheli
cell
caus
airway
damag
tissu
remodel
inde
increas
number
apoptot
epitheli
cell
detect
lung
patient
asthma
compar
healthi
individu
apoptosi
subsequ
uptak
phagocyt
appear
predomin
mechan
eosinophil
remov
airway
glucocorticoid
commonli
use
control
inflamm
asthma
induc
eosinophil
apoptosi
observ
indic
high
effici
phagocyt
system
requir
remov
larg
quantiti
apoptot
eosinophil
bronchial
epitheli
cell
airway
patient
asthma
rais
possibl
defect
efferocytosi
might
prevent
resolut
lung
inflamm
initi
studi
hyunh
et
al
demonstr
airway
macrophag
patient
sever
asthma
contain
reduc
number
phagocyt
bodi
compar
healthi
donor
patient
mildmoder
asthma
defect
phagocytos
apoptot
jurkat
cell
vitro
failur
airway
macrophag
patient
sever
asthma
effici
clear
apoptot
cell
associ
reduc
product
antiinflammatori
eicosanoid
suggest
defect
efferocytosi
might
contribut
perpetu
inflamm
asthma
secondari
necrosi
apoptot
cell
also
reduc
releas
regulatori
mediat
normal
produc
upon
recognit
apoptot
cell
airway
macrophag
recent
shown
efferocytosi
apoptot
bronchial
epitheli
cell
airway
macrophag
isol
induc
sputum
patient
noneosinophil
asthma
significantli
reduc
compar
patient
eosinophil
asthma
degre
uptak
impair
compar
observ
copd
observ
might
partli
explain
persist
neutrophilia
aberr
innat
immun
respons
subgroup
patient
efferocytosi
defect
asthma
associ
subtyp
airway
inflamm
also
bmi
index
airway
macrophag
obes
patient
asthma
typic
suffer
sever
diseas
symptom
characteris
significantli
reduc
number
phagocyt
bodi
compar
nonobes
asthmat
notabl
defect
efferocyt
function
obes
asthmat
restrict
site
inflamm
decreas
uptak
bead
mimick
apoptot
cell
also
observ
peripher
blood
monocyt
isol
patient
correl
reduc
glucocorticoid
respons
report
provid
clear
evid
remov
apoptot
cell
defect
asthma
particular
certain
diseas
subtyp
addit
studi
need
characteris
molecular
mechan
underli
observ
defect
even
though
potenti
chang
express
function
receptor
recognis
apoptot
cell
airway
macrophag
formal
studi
asthma
import
note
tim
receptor
famili
member
preferenti
express
specif
lymphocyt
popul
import
suscept
gene
allerg
asthma
target
modul
airway
inflamm
mous
model
airway
hyperrespons
least
part
interact
nkt
cell
ptdser
surfac
apoptot
cell
observ
suggest
recognit
ptdser
immun
cell
phagocytos
apoptot
cell
also
profound
effect
develop
chronic
lung
inflamm
also
indic
futur
studi
molecul
involv
apoptot
cell
bind
asthma
restrict
analys
airway
macrophag
main
contributor
apoptot
cell
clearanc
inflam
airway
interestingli
efferocytosi
also
engulf
bacteria
airway
macrophag
impair
asthma
find
indic
alter
intracellular
molecular
machineri
regul
phagocytosi
rather
chang
express
receptor
recognis
apoptot
cell
might
respons
observ
phagocytosi
defect
final
previou
studi
sole
focus
efferocytosi
airway
macrophag
mount
evid
suggest
bronchial
epitheli
cell
might
equal
import
clear
apoptot
cell
inflam
airway
even
though
epitheli
cell
profession
phagocyt
effici
engulf
apoptot
eosinophil
neutrophil
anim
studi
demonstr
critic
role
airway
epitheli
cell
remov
apoptot
cell
inflam
lung
consequ
control
inflammatori
respons
murin
model
allerg
airway
hyperrespons
futur
studi
human
therefor
necessari
characteris
rel
contribut
airway
macrophag
bronchial
epitheli
cell
defect
apoptot
cell
remov
asthma
identifi
therapeut
strategi
could
restor
andor
promot
efferocyt
function
cell
type
well
activ
antiinflammatori
transcript
programm
associ
apoptot
cell
recognit
cystic
fibrosi
cf
herit
disord
caus
mutat
cf
transmembran
conduct
regul
cftr
characteris
sever
pulmonari
manifest
impair
mucociliari
clearanc
cf
patient
prevent
elimin
bacteria
lung
lead
persist
neutrophil
inflamm
progress
irrevers
damag
airway
similar
lung
diseas
associ
chronic
inflamm
accumul
apoptot
cell
airway
reduc
number
phagocyt
bodi
within
sputum
macrophag
observ
patient
cf
compar
control
patient
chronic
bronchiti
mechanist
degranul
product
immun
cell
partli
respons
efferocytosi
defect
cf
neutrophil
elastas
present
airway
fluid
cf
patient
select
cleav
ptdser
recognit
receptor
suppress
apoptot
cell
remov
airway
macrophag
potenti
mechan
contribut
impair
apoptot
cell
clearanc
cf
involv
releas
similar
copd
elev
sputum
sampl
cf
patient
effect
bacteri
product
airway
macrophag
pseudomona
aeruginosa
infect
common
cf
repres
import
caus
mortal
cf
lung
manifest
vitro
p
aeruginosa
toxic
metabolit
pyocyanin
polysaccharid
algin
inhibit
apoptot
cell
uptak
macrophag
though
relev
mechan
patient
yet
demonstr
interestingli
anim
studi
indic
airway
epitheli
cell
cf
might
also
defici
phagocyt
function
defect
efferocytosi
airway
macrophag
cf
patient
consequ
ongo
inflammatori
respons
andor
microbi
infect
impair
apoptot
cell
uptak
epitheli
cell
might
directli
relat
lack
cftr
express
cftrdefici
epitheli
cell
express
significantli
increas
level
rhoa
neg
regul
efferoctyosi
rhoa
inhibit
restor
phagocyt
function
remain
determin
similar
mechan
regul
bronchial
epitheli
cell
efferocytosi
patient
cf
elev
level
apoptot
cell
reduc
frequenc
phagocyt
bodi
within
bronchoalveolar
lavag
macrophag
also
report
patient
idiopath
pulmonari
fibrosi
ipf
ipf
interstiti
lung
diseas
characteris
epitheli
injuri
follow
aberr
alveolar
wound
repair
scar
format
ultim
lead
respiratori
failur
death
ipf
frequent
accompani
chronic
neutrophil
inflamm
interestingli
intratrach
instil
apoptot
cell
amelior
fibrosi
inflamm
bleomycininduc
lung
injuri
mice
indic
signal
trigger
apoptot
cell
recognit
may
play
protect
role
lung
diseas
associ
dysregul
heal
process
antifibrot
effect
apoptot
cell
model
depend
induct
express
airway
macrophag
increas
product
hepatocyt
growth
factor
hgf
play
key
role
alveolar
epitheli
repair
upon
lung
injuri
observ
suggest
defect
efferocytosi
ipf
patient
may
respons
ineffici
clearanc
apoptot
cell
also
diminish
product
factor
support
tissu
repair
without
fibrosi
collect
data
patient
asthma
copd
cf
pulmonari
fibrosi
indic
defect
apoptot
cell
clearanc
lung
diseas
specif
individu
diagnos
rather
repres
gener
hallmark
chronic
inflamm
although
sever
mechan
contribut
defect
propos
remain
verifi
whether
impair
efferocytosi
might
direct
caus
chronic
inflamm
consequ
ongo
inflammatori
process
contribut
chronic
prevent
resolut
latter
model
support
observ
mice
lack
tam
receptor
axl
develop
spontan
lung
inflamm
despit
defect
apoptot
cell
uptak
airway
macrophag
detail
analys
regul
function
ptdser
recognit
receptor
human
lung
requir
final
recognit
apoptot
cell
ptdserrecognis
receptor
activ
downstream
signal
pathway
even
without
engulf
futur
studi
need
verifi
whether
activ
transcript
programm
trigger
recognit
apoptot
cell
also
alter
chronic
lung
diseas
manipul
clinic
specif
modul
ptdser
recognit
receptor
steril
inflamm
recognit
apoptot
cell
immun
system
typic
result
suppress
ongo
inflammatori
respons
complex
process
biolog
effect
greatli
increas
context
microbi
infect
first
envelop
virus
use
ptdser
receptor
promot
entri
host
cell
facilit
infect
immun
evas
interact
ptdser
expos
surfac
viral
envelop
member
tam
tim
receptor
famili
express
target
cell
enabl
proxim
specif
entri
receptor
enhanc
engulf
viru
fig
relev
process
call
apoptot
mimicri
recent
confirm
broad
rang
virion
includ
ebola
dengu
virus
thu
far
howev
littl
known
potenti
role
entri
mechan
pulmonari
viral
infect
observ
kinet
influenza
viru
clearanc
unaffect
axldefici
mice
indirectli
indic
axl
import
control
infect
though
interact
formal
test
similarli
although
promot
internalis
replic
sever
envelop
virus
entri
lead
product
infect
influenza
sever
acut
respiratori
syndrom
sar
coronaviru
argu
import
role
apoptot
mimicri
viral
lung
diseas
second
mani
pathogen
surviv
intracellularli
phagocytosi
infect
host
cell
undergo
apoptosi
divers
consequ
pathogen
surviv
immun
respons
host
one
main
strategi
immun
system
control
intracellular
infect
induct
apoptosi
infect
cell
engulf
destroy
togeth
pathogen
phagocyt
fig
howev
case
efferocytosi
infect
cell
use
intracellular
pathogen
parasit
leishmania
major
evad
immun
respons
gain
entri
new
cellular
host
among
pathogen
import
respiratori
diseas
role
efferocytosi
thoroughli
studi
context
mycobacterium
tuberculosi
infect
tuberculosi
infect
macrophag
induc
necrosi
host
cell
avoid
clearanc
immun
system
dissemin
interestingli
tuberculosisinfect
mous
macrophag
die
apoptosi
rapidli
efferocytos
uninfect
macrophag
lead
bacteri
kill
elimin
bactericid
effect
depend
efferocytosi
uptak
nake
tuberculosi
allow
lysosom
recruit
bacteriacontain
phagosom
inhibit
apoptot
cell
uptak
antibodi
prevent
bacteri
control
vitro
increas
bacteri
burden
lung
vivo
observ
bactericid
activ
macrophag
infect
streptococcu
pneumonia
depend
induct
macrophag
apoptosi
suggest
similar
mechan
might
involv
control
infect
bacterium
though
involv
efferocytosi
process
formal
proven
engulf
macrophagederiv
apoptot
vesicl
also
play
critic
though
indirect
role
adapt
immun
respons
tuberculosi
annexin
uptak
apoptot
cell
dendrit
cell
requir
crosspresent
gener
tuberculosisspecif
cell
respons
bacteri
clearanc
lung
antimicrobi
role
apoptot
cell
clearanc
pulmonari
infect
restrict
bacteria
influenza
viru
induc
apoptosi
epitheli
cell
upon
infect
engulf
influenza
ainfect
cell
macrophag
associ
reduct
viral
titr
hand
infect
macrophag
francisella
novicida
member
francisellacea
famili
intracellular
bacteria
caus
pulmonari
inflamm
associ
necrot
infiltr
lung
reduc
efferocyt
function
potenti
contribut
accumul
necrot
cell
debri
exacerb
diseas
taken
togeth
studi
suggest
efferocytosi
constitut
function
macrophag
requir
maintain
immun
homeostasi
health
inflammatori
respons
also
import
antimicrobi
effector
mechan
howev
note
apart
bactericid
activ
specif
pathogen
antiinflammatori
signal
associ
apoptot
cell
uptak
phagocyt
might
prevent
mount
effici
immun
respons
context
lung
infect
prior
exposur
mous
airway
macrophag
apoptot
cell
result
suppress
fcrmediat
phagocytosi
kill
bacteria
intrapulmonari
administr
apoptot
cell
caus
signific
impair
pneumonia
clearanc
infect
lung
suppress
antimicrobi
respons
airway
macrophag
also
augment
glucocorticoid
promot
efferocytosi
treatment
mice
apoptot
cell
presenc
glucocorticoid
associ
elev
bacteri
burden
lung
even
though
valid
observ
human
system
necessari
clearli
indic
efferocytosi
play
dual
role
lung
infect
effici
apoptot
cell
uptak
requir
resolut
inflammatori
respons
elimin
certain
intracellular
pathogen
antiinflammatori
programm
activ
upon
prolong
exposur
apoptot
cell
might
increas
suscept
secondari
infect
infectionrel
exacerb
chronic
inflammatori
lung
diseas
light
import
effercotysi
resolut
inflamm
report
defect
apoptot
cell
remov
chronic
inflammatori
lung
diseas
surpris
evalu
potenti
therapeut
strategi
aim
enhanc
apoptot
cell
uptak
gain
lot
attent
recent
year
strikingli
glucocorticoid
commonli
use
class
drug
treatment
asthma
copd
increas
apoptot
cell
engulf
macrophag
vitro
restor
efferocyt
function
airway
macrophag
patient
sever
asthma
upregul
tam
receptor
mertk
downregul
might
respons
proefferocyt
activ
glucocorticoid
macrophag
howev
remain
unknown
whether
promot
apoptot
cell
clearanc
significantli
contribut
antiinflammatori
effect
glucocorticoid
patient
lung
diseas
systemat
analys
apoptot
cell
accumul
efferocyt
function
airway
macrophag
glucocorticoid
therapi
respond
nonrespond
therefor
necessari
address
question
class
medic
wide
use
clinic
indic
also
promot
efferocytosi
antibiot
azithromycin
increas
phagocytosi
apoptot
cell
human
airway
macrophag
vitro
signific
improv
efferocyt
function
airway
macrophag
copd
patient
oral
treatment
azithromycin
report
light
recent
evid
azithromycin
reduc
frequenc
exacerb
copd
patient
tempt
specul
least
part
immunomodulatori
activ
macrolid
antibiot
attribut
effect
apoptot
cell
clearanc
similarli
agonist
use
insulin
sensit
diabet
mellitu
also
display
broad
antiinflammatori
effect
promot
efferocytosi
airway
macrophag
vitro
amelior
diseas
symptom
anim
model
pulmonari
inflamm
enhanc
apoptot
cell
engulf
also
observ
treatment
macrophag
copd
patient
simvastatin
member
statin
famili
cholesterollow
drug
retrospect
studi
suggest
statin
might
reduc
risk
copd
exacerb
mortal
recent
howev
larg
randomis
clinic
trial
simvastatin
treatment
effect
exacerb
rate
copd
patient
though
efferocyt
function
airway
macrophag
analys
studi
remain
open
question
patient
copd
stratifi
identifi
subgroup
patient
respond
statin
treatment
whether
relat
effect
apoptot
cell
clearanc
final
observ
aberr
express
activ
tam
receptor
axl
oncogen
function
haematolog
epitheli
malign
trigger
interest
target
activ
ptdser
recognit
receptor
small
molecul
inhibitor
axl
current
phase
clinic
trial
howev
preclin
studi
indic
pharmacolog
modul
ptdser
recognit
receptor
might
signific
impact
immun
system
especi
context
lung
immunopatholog
light
critic
role
axl
resolut
lung
inflamm
upon
influenza
infect
attempt
target
axl
activ
system
proceed
caution
due
potenti
advers
event
relat
exagger
inflammatori
respons
respiratori
infect
similar
axl
mertk
signal
also
requir
silenc
lung
inflamm
inhibit
mertk
proteolyt
cleavag
inhibitor
restor
mertk
express
attenu
inflamm
lpsinduc
lung
injuri
wherea
administr
mertk
block
antibodi
opposit
effect
result
suggest
activ
antibodi
compound
prevent
shed
tam
receptor
could
benefici
context
chronic
lung
diseas
inde
tam
receptor
activ
independ
apoptot
cell
engulf
specif
antibodi
though
effect
test
model
lung
inflamm
regard
noteworthi
activ
tam
receptor
lead
shed
extracellular
domain
solubl
form
tam
receptor
act
decoy
receptor
suppress
apoptot
cell
engulf
macrophag
although
alter
level
solubl
tam
receptor
note
sever
patholog
physiolog
role
still
poorli
understood
remain
unknown
administr
antibodi
target
tam
receptor
would
caus
sequestr
consequ
would
immun
homeostasi
lung
sinc
initi
discoveri
defect
apoptot
cell
clearanc
asthma
copd
great
progress
made
understand
molecular
mechan
efferocytosi
sever
new
process
efferocytosi
modul
host
immun
respons
characteris
fig
consequ
new
question
emerg
regard
role
apoptot
cell
remov
lung
homeostasi
import
list
box
futur
studi
address
question
especi
attempt
therapeut
manipul
efferocytosi
clinic
design
context
multipl
role
apoptot
cell
phagocytosi
resolut
inflamm
microbi
infect
box
futur
question
apoptot
cell
remov
airspac
efferocytosi
polaris
airway
macrophag
phenotyp
polaris
airway
macrophag
better
efferocytosi
impact
tissu
microenviron
apoptot
cell
recognit
receptor
repertoir
outcom
ligat
homeostat
apoptot
cell
clearanc
differ
requir
consequ
clearanc
cell
inflamm
impact
alter
lung
environ
asthma
copd
cf
apoptot
cell
clearanc
open
access
articl
distribut
term
creativ
comm
on
attribut
intern
licens
http
permit
unrestrict
use
distribut
reproduct
medium
provid
give
appropri
credit
origin
author
sourc
provid
link
creativ
common
licens
indic
chang
made
